3(2H)-Pyridazinone, 4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-[(3-pyridinylmethyl)amino]-, hydrochloride (1:1)

Request For Quotation
3(2H)-Pyridazinone, 4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-[(3-pyridinylmethyl)amino]-, hydrochloride (1:1) Basic information
Product Name:3(2H)-Pyridazinone, 4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-[(3-pyridinylmethyl)amino]-, hydrochloride (1:1)
Synonyms:3(2H)-Pyridazinone, 4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-[(3-pyridinylmethyl)amino]-, hydrochloride (1:1)
CAS:139145-84-9
MF:C19H18BrClN4O2.ClH
MW:486.19
EINECS:
Product Categories:
Mol File:139145-84-9.mol
3(2H)-Pyridazinone, 4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-[(3-pyridinylmethyl)amino]-, hydrochloride (1:1) Structure
3(2H)-Pyridazinone, 4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-[(3-pyridinylmethyl)amino]-, hydrochloride (1:1) Chemical Properties
Safety Information
MSDS Information
3(2H)-Pyridazinone, 4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-[(3-pyridinylmethyl)amino]-, hydrochloride (1:1) Usage And Synthesis
UsesParogrelil (hydrochloride) (NM-702) is a phosphodiesterase inhibitor with activity in inhibiting intermittent claudication. Parogrelil (hydrochloride) selectively inhibits PDE3, inhibits human platelet aggregation in vitro and rat aortic contraction, and improves walking distance and plantar surface temperature in the rat femoral artery ligation model, with better effects than cilostazol.
References[1] NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase inhibitor, improves reduced walking distance and lowered hindlimb plantar surface temperature in a rat experimental intermittent claudication model
3(2H)-Pyridazinone, 4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-[(3-pyridinylmethyl)amino]-, hydrochloride (1:1) Preparation Products And Raw materials
Tag:3(2H)-Pyridazinone, 4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-[(3-pyridinylmethyl)amino]-, hydrochloride (1:1)(139145-84-9) Related Product Information
Ro 20-1724 Apremilast Cilostamide Tadalafil Cilostazol Sildenafil